BACKGROUND AND AIMS: Changes in the expression of signal transducer and activator of transcription 4 (STAT4) contribute to the development of a variety of autoimmune diseases including inflammatory bowel diseases (IBDs). Moreover, epigenetic modifications, including DNA methylation, are considered a basis for differentiation of T helper cells and regulation of cytokines. In this study, we investigated the methylation status of STAT4 gene in IBD patients and the associations between its genetic and epigenetic alterations in IBD patients. METHODS: Blood and colonic mucosa samples were obtained from Korean patients with IBD and healthy controls. Peripheral blood mononuclear cells (PBMCs) were isolated, and total RNA and genomic DNA were isolated from the PBMCs and colon mucosa tissues. The mRNA level and DNA methylation status of the promoter were determined by real-time RT-PCR and pyrosequencing, respectively. The chosen SNPs (rs11889341, rs7574865, rs8179673, rs6752770, rs925847, rs10168266, rs10181656, and rs11685878) were genotyped using the TaqMan nuclease assay. RESULTS: Elevated expression of STAT4 was observed in the colonic mucosa and PBMCs of IBD patients. IBD patients showed a lower degree of methylation of the STAT4 promoter than did the healthy controls. Moreover, a significant correlation between risk alleles and methylation status at -172 of the STAT4 promoter was observed, and mRNA levels of STAT4 in IBD patients were correlated inversely with the T-risk allele (rs7574865). CONCLUSIONS: Our data demonstrated that the DNA methylation status of STAT4 is associated with genetic polymorphisms, providing insights into the interactions between genetic and epigenetic aberrances in STAT4 that contribute to the development of IBD.
BACKGROUND AND AIMS: Changes in the expression of signal transducer and activator of transcription 4 (STAT4) contribute to the development of a variety of autoimmune diseases including inflammatory bowel diseases (IBDs). Moreover, epigenetic modifications, including DNA methylation, are considered a basis for differentiation of T helper cells and regulation of cytokines. In this study, we investigated the methylation status of STAT4 gene in IBDpatients and the associations between its genetic and epigenetic alterations in IBDpatients. METHODS: Blood and colonic mucosa samples were obtained from Korean patients with IBD and healthy controls. Peripheral blood mononuclear cells (PBMCs) were isolated, and total RNA and genomic DNA were isolated from the PBMCs and colon mucosa tissues. The mRNA level and DNA methylation status of the promoter were determined by real-time RT-PCR and pyrosequencing, respectively. The chosen SNPs (rs11889341, rs7574865, rs8179673, rs6752770, rs925847, rs10168266, rs10181656, and rs11685878) were genotyped using the TaqMan nuclease assay. RESULTS: Elevated expression of STAT4 was observed in the colonic mucosa and PBMCs of IBDpatients. IBDpatients showed a lower degree of methylation of the STAT4 promoter than did the healthy controls. Moreover, a significant correlation between risk alleles and methylation status at -172 of the STAT4 promoter was observed, and mRNA levels of STAT4 in IBDpatients were correlated inversely with the T-risk allele (rs7574865). CONCLUSIONS: Our data demonstrated that the DNA methylation status of STAT4 is associated with genetic polymorphisms, providing insights into the interactions between genetic and epigenetic aberrances in STAT4 that contribute to the development of IBD.
Authors: Z Lin; J P Hegarty; J A Cappel; W Yu; X Chen; P Faber; Y Wang; A A Kelly; L S Poritz; B Z Peterson; S Schreiber; J-B Fan; W A Koltun Journal: Clin Genet Date: 2010-10-18 Impact factor: 4.438
Authors: Chang Mo Moon; Jae Hee Cheon; Seung Won Kim; Dong-Jik Shin; Eun Soo Kim; Eun-Soon Shin; Yoon Kang; Jae Jun Park; Sung Pil Hong; Su Youn Nam; Tae Il Kim; Won Ho Kim Journal: Life Sci Date: 2010-02-20 Impact factor: 5.037
Authors: Maritta Pykäläinen; Riikka Kinos; Sanna Valkonen; Pia Rydman; Maritta Kilpeläinen; Lauri A Laitinen; Jussi Karjalainen; Markku Nieminen; Mikko Hurme; Juha Kere; Tarja Laitinen; Riitta Lahesmaa Journal: J Allergy Clin Immunol Date: 2005-01 Impact factor: 10.793
Authors: B Rueda; J Broen; C Simeon; R Hesselstrand; B Diaz; H Suárez; N Ortego-Centeno; G Riemekasten; V Fonollosa; M C Vonk; F H J van den Hoogen; J Sanchez-Román; M A Aguirre-Zamorano; R García-Portales; A Pros; M T Camps; M A Gonzalez-Gay; M J H Coenen; P Airo; L Beretta; R Scorza; J van Laar; M F Gonzalez-Escribano; J L Nelson; T R D J Radstake; J Martin Journal: Hum Mol Genet Date: 2009-03-13 Impact factor: 6.150
Authors: Silvia N Kariuki; Kyriakos A Kirou; Emma J MacDermott; Lilliana Barillas-Arias; Mary K Crow; Timothy B Niewold Journal: J Immunol Date: 2009-01-01 Impact factor: 5.422
Authors: Carl A Anderson; Gabrielle Boucher; Charlie W Lees; Andre Franke; Mauro D'Amato; Kent D Taylor; James C Lee; Philippe Goyette; Marcin Imielinski; Anna Latiano; Caroline Lagacé; Regan Scott; Leila Amininejad; Suzannah Bumpstead; Leonard Baidoo; Robert N Baldassano; Murray Barclay; Theodore M Bayless; Stephan Brand; Carsten Büning; Jean-Frédéric Colombel; Lee A Denson; Martine De Vos; Marla Dubinsky; Cathryn Edwards; David Ellinghaus; Rudolf S N Fehrmann; James A B Floyd; Timothy Florin; Denis Franchimont; Lude Franke; Michel Georges; Jürgen Glas; Nicole L Glazer; Stephen L Guthery; Talin Haritunians; Nicholas K Hayward; Jean-Pierre Hugot; Gilles Jobin; Debby Laukens; Ian Lawrance; Marc Lémann; Arie Levine; Cecile Libioulle; Edouard Louis; Dermot P McGovern; Monica Milla; Grant W Montgomery; Katherine I Morley; Craig Mowat; Aylwin Ng; William Newman; Roel A Ophoff; Laura Papi; Orazio Palmieri; Laurent Peyrin-Biroulet; Julián Panés; Anne Phillips; Natalie J Prescott; Deborah D Proctor; Rebecca Roberts; Richard Russell; Paul Rutgeerts; Jeremy Sanderson; Miquel Sans; Philip Schumm; Frank Seibold; Yashoda Sharma; Lisa A Simms; Mark Seielstad; A Hillary Steinhart; Stephan R Targan; Leonard H van den Berg; Morten Vatn; Hein Verspaget; Thomas Walters; Cisca Wijmenga; David C Wilson; Harm-Jan Westra; Ramnik J Xavier; Zhen Z Zhao; Cyriel Y Ponsioen; Vibeke Andersen; Leif Torkvist; Maria Gazouli; Nicholas P Anagnou; Tom H Karlsen; Limas Kupcinskas; Jurgita Sventoraityte; John C Mansfield; Subra Kugathasan; Mark S Silverberg; Jonas Halfvarson; Jerome I Rotter; Christopher G Mathew; Anne M Griffiths; Richard Gearry; Tariq Ahmad; Steven R Brant; Mathias Chamaillard; Jack Satsangi; Judy H Cho; Stefan Schreiber; Mark J Daly; Jeffrey C Barrett; Miles Parkes; Vito Annese; Hakon Hakonarson; Graham Radford-Smith; Richard H Duerr; Séverine Vermeire; Rinse K Weersma; John D Rioux Journal: Nat Genet Date: 2011-02-06 Impact factor: 38.330
Authors: William E Yang; Sunil Suchindran; Bradly P Nicholson; Micah T McClain; Thomas Burke; Geoffrey S Ginsburg; Clayton D Harro; Subhra Chakraborty; David A Sack; Christopher W Woods; Ephraim L Tsalik Journal: J Infect Dis Date: 2016-01-18 Impact factor: 5.226
Authors: Isabella Dotti; Rut Mora-Buch; Elena Ferrer-Picón; Núria Planell; Peter Jung; M Carme Masamunt; Raquel Franco Leal; Javier Martín de Carpi; Josep Llach; Ingrid Ordás; Eduard Batlle; Julián Panés; Azucena Salas Journal: Gut Date: 2016-11-01 Impact factor: 23.059